高级检索
当前位置: 首页 > 详情页

Value Proposition of Retinal Imaging in Alzheimer's Disease Screening: A Review of Eight Evolving Trends

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China [2]Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong SAR, China. [3]NIHR Biomedical Research Center at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK. [4]Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR China [5]Gerald Choa Neuroscience Institute, Margaret K.L. Cheung Research Centre for Management of Parkinsonism, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, Li Ka Shing Institute of Health Science, Lau Tat-chuen Research Centre of Brain Degenerative Diseases in Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR China. [6]Departments of Ophthalmology and Neurology, Duke University School of Medicine, Durham, North Carolina, USA. [7]Beijing Institute of Ophthalmology, Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Hospital, Capital University of Medical Science, Beijing, China. [8]Department of Ophthalmology, University of Washington, Seattle, WA, USA. [9]Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [10]Singapore National Eye Centre, Singapore. [11]Memory Aging & Cognition Centre, National University Health System, Singapore [12]Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [13]Tsinghua Medicine, Tsinghua University, Beijing, China.
出处:
ISSN:

摘要:
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Current diagnostic modalities of AD generally focus on detecting the presence of amyloid β and tau protein in the brain (for example, positron emission tomography [PET] and cerebrospinal fluid testing), but these are limited by their high cost, invasiveness, and lack of expertise. Retinal imaging exhibits potential in AD screening and risk stratification, as the retina provides a platform for the optical visualization of the central nervous system in vivo, with vascular and neuronal changes that mirror brain pathology. Given the paradigm shift brought by advances in artificial intelligence and the emergence of disease-modifying therapies, this article aims to summarize and review the current literature to highlight 8 trends in an evolving landscape regarding the role and potential value of retinal imaging in AD screening.Copyright © 2024. Published by Elsevier Ltd.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版
大类 | 1 区 医学
小类 | 1 区 眼科学
最新[2023]版
大类 | 1 区 医学
小类 | 1 区 眼科学
JCR分区:
出版当年[2022]版:
Q1 OPHTHALMOLOGY
最新[2023]版:
Q1 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China [2]Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong SAR, China.
通讯作者:
通讯机构: [4]Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR China [5]Gerald Choa Neuroscience Institute, Margaret K.L. Cheung Research Centre for Management of Parkinsonism, Therese Pei Fong Chow Research Centre for Prevention of Dementia, Lui Che Woo Institute of Innovative Medicine, Li Ka Shing Institute of Health Science, Lau Tat-chuen Research Centre of Brain Degenerative Diseases in Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR China. [11]Memory Aging & Cognition Centre, National University Health System, Singapore [12]Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)